Pear Therapeutics’ $1.6 Billion Business Combination with Thimble Point Acquisition Corp.

Martina Bellini
Tagged:

Goodwin Procter LLP advised Pear Therapeutics on the deal.Pear Therapeutics announced its definitive business combination agreement with Thimble Point Acquisition Corp. (Nasdaq: THMA), a special purpose acquisition…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now